The Protein Chemistry and Mass Spectrometry ('Proteomics') Core will be under the administration of theBuck Institute's Chemistry Program whose director is Dr. Gibson. Dr. Gibson has over 20 years experiencein mass spectrometry and the analysis of proteins and other macromolecules. In the last seven years, thisgroup has carried out extensive studies in mitochondrial proteomics as well as developing new methods tostudy posttranslational modifications such as 3-nitrotyrosine, phosphorylation and cysteine oxidation. Theproteomics facilities in the Core include extensive mass spectrometry, chromatography, and proteinchemistry components that are well suited to provide the expertise and methodology needed to carry out theprotein chemistry experiments described in Projects 1-3. The resources and knowledge of the Core staffinclude methods for mitochondrial proteomics, protein identification, chemistry and quantitation, Moreover,methods have been described for the rapid isolation and analysis of large complexes (e.g., mitochondrialelectron transport chain, or ETC), and the analysis of protein posttranslational modifications (PTMs),including oxidative damage, protein phosphorylation, and changes in subunit stoichiometries. Therefore,our aims for this Core are to work closely with the PL's of the individual Projects to provide detailedanalysis of proteins, i.e., mitochondrial OXPHOS complexes I-V, p53 and tau as well as other proteins, andchanges they undergo in response to the manipulation of genes/enzymes that affect the overall redox status,or 'oxidative stress' of the various age-related disease cell and/or animal model systems.
The specific aims of the Proteomics Core in relation to the three Projects in this Program Project are:Andersen, Project 1: We will examine in detail both oxidative damage (both reversible and irreversible) andchanges in phosphorylation among the 46 subunits of mitochondrial Complex I (and possibly other ETCcomplexes and mitochondrial proteins) that accompany acute and/or chronic depletion of glutathione poolsin an transgenic anti-GCLmouse and a rat dopaminergic N27 cell line.Campisi and Benz, Project 2: We will examine changes in p53 phosphorylation and cysteinyl redox status(i.e., glutathionylation, cysteic acid, etc.) in human and mouse epithelial fibroblasts (MEFs) when SOD2,glutathione and p53 expression levels have been manipulated and correlated to changes in either p53 levelsor DNA binding.Melov Project 3: We will examine changes in the phosphorylation state of tau in a constituitive and, at laterstages, an inducible sod2 nullizygous mouse model as a consequence of age and oxidative stress.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG025901-01A2
Application #
7183911
Study Section
Special Emphasis Panel (ZAG1-ZIJ-2 (O2))
Project Start
2006-12-01
Project End
2011-11-30
Budget Start
2006-12-01
Budget End
2008-02-29
Support Year
1
Fiscal Year
2007
Total Cost
$214,336
Indirect Cost
Name
Buck Institute for Age Research
Department
Type
DUNS #
786502351
City
Novato
State
CA
Country
United States
Zip Code
94945
Leonoudakis, Dmitri; Rane, Anand; Angeli, Suzanne et al. (2017) Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease. Mediators Inflamm 2017:8302636
Siddiqui, Almas; Rane, Anand; Rajagopalan, Subramanian et al. (2016) Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha. Neurobiol Dis 93:115-20
Siddiqui, Almas; Bhaumik, Dipa; Chinta, Shankar J et al. (2015) Mitochondrial Quality Control via the PGC1?-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin. J Neurosci 35:12833-44
Chinta, Shankar J; Woods, Georgia; Rane, Anand et al. (2015) Cellular senescence and the aging brain. Exp Gerontol 68:3-7
Velarde, Michael C; Demaria, Marco; Melov, Simon et al. (2015) Pleiotropic age-dependent effects of mitochondrial dysfunction on epidermal stem cells. Proc Natl Acad Sci U S A 112:10407-12
Laberge, Remi-Martin; Sun, Yu; Orjalo, Arturo V et al. (2015) MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 17:1049-61
Lieu, Christopher A; Dewey, Colleen M; Chinta, Shankar J et al. (2014) Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model. Brain Res 1591:111-7
Quinlan, Casey L; Perevoschikova, Irina V; Goncalves, Renata L S et al. (2013) The determination and analysis of site-specific rates of mitochondrial reactive oxygen species production. Methods Enzymol 526:189-217
Chinta, S J; Lieu, C A; Demaria, M et al. (2013) Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease? J Intern Med 273:429-36
Quinlan, Casey L; Perevoshchikova, Irina V; Hey-Mogensen, Martin et al. (2013) Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol 1:304-12

Showing the most recent 10 out of 78 publications